414
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

, , , , , , & show all
Pages 1-19 | Published online: 17 Dec 2018

References

  • BeghiEAddressing the burden of epilepsy: many unmet needsPharmacol Res2016107798426952026
  • FiestKMSauroKMWiebeSPrevalence and incidence of epilepsy: a systematic review and meta-analysis of international studiesNeurology201788329630327986877
  • OlesenJGustavssonASvenssonMThe economic cost of brain disorders in EuropeEur J Neurol201219115516222175760
  • BegleyCEDurginTLThe direct cost of epilepsy in the United States: a systematic review of estimatesEpilepsia20155691376138726216617
  • KortlandLMAlfterABährOCosts and cost-driving factors for acute treatment of adults with status epilepticus: a multicenter cohort study from GermanyEpilepsia201657122056206627753082
  • WillemsLMRichterSWatermannNTrends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 – a ten-year overviewEpilepsy Behav201883283529649671
  • Epilepsies: diagnosis and management (clinical guideline [CG137]) Available from: https://www.nice.org.uk/guidance/cg137Accessed July 18, 2017
  • ZhuFLangSYWangXQLong-term effectiveness of antiepileptic drug monotherapy in partial epileptic patients: a 7-year study in an epilepsy center in ChinaChin Med J2015128223015302226608980
  • MatagneAMargineanuDGKendaBMichelPKlitgaardHAnti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2ABr J Pharmacol200815481662167118500360
  • RigoJMHansGNguyenLThe anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currentsBr J Pharmacol2002136565967212086975
  • DeshpandeLSDelorenzoRJMechanisms of levetiracetam in the control of status epilepticus and epilepsyFront Neurol201451124550884
  • EmswilerMPCumpstonKLSecond generation anticonvulsants: gabapentin, lamotrigine, levetiracetam, and topiramate Available from: https://www.researchgate.net/publication/312660054_Second_Generation_Anticonvulsants_Gabapentin_Lamotrigine_Levetiracetam_and_Topiramate?ev=auth_pubAccessed July 18, 2017
  • FrenchJEdrichPCramerJAA systematic review of the safety profile of levetiracetam: a new antiepileptic drugEpilepsy Res2001471–2779011673023
  • SpencerDLevetiracetam in men with epilepsy: testosterone is left alone but sperm count is paramountEpilepsy Curr20171729910028490999
  • FaganAFuldJSoonELevetiracetam-induced eosinophilic pneumoniaBMJ Case Rep20172017bcr2016219121
  • KimJShinJWLevetiracetam-induced thrombocytopenia in a patient with status epilepticusEpileptic Disord201719110410828202425
  • di LorenzoRLiYRhabdomyolysis associated with levetiracetam administrationMuscle Nerve2017561E1E228039868
  • SheaBJGrimshawJMWellsGADevelopment of AMSTAR: a measurement tool to assess the methodological quality of systematic reviewsBMC Med Res Methodol2007711017302989
  • HigginsJPAltmanDGGøtzschePCThe Cochrane Collaboration’s tool for assessing risk of bias in randomised trialsBMJ2011343d592822008217
  • WellsGASheaBO’ConnellDThe Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspAccessed July 18, 2017
  • HusereauDDrummondMPetrouSConsolidated Health Economic Evaluation Reporting Standards (CHEERS) statementValue Health2013162e1e523538200
  • SirvenJIFifeTDWingerchukDMDrazkowskiJFSecond-generation antiepileptic drugs’ impact on balance: a meta-analysisMayo Clin Proc2007821404717285784
  • CostaJFareleiraFAscençãoRBorgesMSampaioCVaz-CarneiroAClinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysisEpilepsia20115271280129121729036
  • LoBWKyuHHJichiciDUptonAMAklEAMeadeMOMeta-analysis of randomized trials on first line and adjunctive levetiracetamCan J Neurol Sci201138347548621515509
  • HanHQuWKangHEffect of second-generation antiepileptic drugs on diplopia: a meta-analysis of placebo-controlled studiesJ Huazhong Univ Sci Technolog Med Sci201232455756222886970
  • MaguireMMarsonAGRamaratnamSEpilepsy (generalized)BMJ Clin Evid201220121201
  • MbizvoGKDixonPHuttonJLMarsonAGLevetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane ReviewCochrane Database Syst Rev201299CD001901
  • PiedadJRickardsHBesagFMCavannaAEBeneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitationsCNS Drugs201226431933522393904
  • AryaRGlauserTAPharmacotherapy of focal epilepsy in children: a systematic review of approved agentsCNS Drugs201327427328623515971
  • BodaliaPNGrossoAMSofatRComparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trialsBr J Clin Pharmacol201376564966723351090
  • FangYWuXXuLRandomized-controlled trials of levetiracetam as an adjunctive therapy in epilepsy of multiple seizure typesJ Clin Neurosci2014211556224231559
  • HalmaEde LouwAJKlinkenbergSAldenkampAPIjffDMMajoieMBehavioral side-effects of levetiracetam in children with epilepsy: a systematic reviewSeizure201423968569124981629
  • MbizvoGKDixonPHuttonJLMarsonAGThe adverse effects profile of levetiracetam in epilepsy: a more detailed lookInt J Neurosci2014124962763424256446
  • FountoulakisKNGondaXBaghaiTCReport of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsyInt J Psychiatry Clin Pract201519315816725547437
  • VerrottiAPreziosoGdi SabatinoFFrancoVChiarelliFZaccaraGThe adverse event profile of levetiracetam: a meta-analysis on children and adultsSeizure201531495526362377
  • WeijenbergABrouwerOFCallenbachPMLevetiracetam monotherapy in children with epilepsy: a systematic reviewCNS Drugs201529537138226013703
  • CamposMSAyresLRMoreloMRMarquesFAPereiraLREfficacy and tolerability of antiepileptic drugs in patients with focal epilepsy: systematic review and network meta-analysesPharmacotherapy201636121255127127779771
  • EgunsolaOChoonaraISammonsHMSafety of levetiracetam in paediatrics: a systematic reviewPLoS One2016113e014968626930201
  • WestonJBromleyRJacksonCFMonotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the childCochrane Database Syst Rev201611CD01022427819746
  • ZhangLLiSLiHZouXLevetiracetam vs. brivaracetam for adults with refractory focal seizures: a meta-analysis and indirect comparisonSeizure201639283327236448
  • GengHWangCEfficacy and safety of oxcarbazepine in the treatment of children with epilepsy: a meta-analysis of randomized controlled trialsNeuropsychiatr Dis Treat20171368569528293110
  • SongJMHahnJKimSHChangMJEfficacy of treatments for infantile spasms: a systematic reviewClin Neuropharmacol2017402638428288483
  • MchughDCLancasterSManganasLNA systematic review of the efficacy of levetiracetam in neonatal seizuresNeuropediatrics2018491012017
  • Mohd-TahirNALiSCMeta-analyses of newer antiepileptic drugs as adjunct for treatment of focal epilepsy in childrenEpilepsy Res201813911312229220742
  • NevittSJSudellMWestonJTudur SmithCMarsonAGAnti-epileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant dataCochrane Database Syst Rev20176CD01141228661008
  • RosatiAIlventoLLucenteforteEComparative efficacy of antiepileptic drugs in children and adolescents: a network meta-analysisEpilepsia201859229731429270989
  • VeronikiAACogoERiosPComparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomesBMC Med20171519528472982
  • VeronikiAARiosPCogoEComparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysisBMJ Open201777e017248
  • ZhangLWangCLiWA meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsyNeuropsychiatr Dis Treat20181476977929559784
  • ZhaoTFengXLiuJGaoJZhouCEvaluate the efficacy and safety of anti-epileptic medications for partial seizures of epilepsy: a network meta-analysisJ Cell Biochem201711892850286428214290
  • ZhuLNChenDXuDTanGWangHJLiuLNewer antiepi-leptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: an indirect comparisonSeizure20175112113228854405
  • BerkovicSFKnowltonRCLeroyRFSchiemannJFalterULevetiracetam N01057 Study GroupPlacebo-controlled study of levetiracetam in idiopathic generalized epilepsyNeurology200769181751176017625106
  • BrodieMJPeruccaERyvlinPBen-MenachemEMeenckeHJLevetiracetam Monotherapy Study GroupComparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsyNeurology200768640240817283312
  • CoppolaGFranzoniEVerrottiALevetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trialBrain Dev200729528128417055681
  • NoachtarSAndermannEMeyvischPLevetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizuresNeurology200870860761618285535
  • ZhouBZhangQTianLXiaoJStefanHZhouDEffects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizuresEpilepsy Behav200812230531018024209
  • LabinerDMEttingerABFakhouryTAEffects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsyEpilepsia200950343444219016830
  • LevisohnPMMintzMHunterSJYangHJonesJN01103 Levetiracetam Study GroupNeurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trialEpilepsia200950112377238919702752
  • LimDATaraporePChangESafety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized Phase II pilot studyJ Neurooncol200993334935419169651
  • PeltolaJCoetzeeCJiménezFOnce-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trialEpilepsia200950340641419317886
  • Piña-GarzaJENordliDRRatingDAdjunctive levetiracetam in infants and young children with refractory partial-onset seizuresEpilepsia20095051141114919243423
  • WuXYHongZWuXMulticenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizuresEpilepsia200950339840518657175
  • XiaoZLiJMWangXFEfficacy and safety of levetiracetam (3,000 mg/day) as an adjunctive therapy in Chinese patients with refractory partial seizuresEur Neurol200961423323919176965
  • CumboELigoriLDLevetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer’s diseaseEpilepsy Behav201017446146620188634
  • de La LogeCHunterSJSchiemannJYangHAssessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trialEpilepsy Behav201018329129820547106
  • UCB Japan Co LtdA double-blind, placebo-controlled study of levetiracetam in epilepsy patients with generalized tonic-clonic seizures (except partial seizures evolving to secondarily generalized seizures) Available from: https://ClinicalTrials.gov/show/NCT01228747Accessed July 18, 2017
  • UCB Korea Co., LtdLevetiracetam versus topiramate as adjunctive therapy to evaluate efficacy and safety in subjects with refractory partial onset seizures Available from: https://ClinicalTrials.gov/show/NCT01229735Accessed July 18, 2017
  • FattoreCBoniverCCapovillaGA multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsyEpilepsia201152480280921320119
  • ConsoliDBoscoDPostorinoPLevetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project)Cerebrovasc Dis201234428228923128439
  • HakamiTTodaroMPetrovskiSSubstitution monotherapy with levetiracetam vs older antiepileptic drugs: a randomized comparative trialArch Neurol201269121563157122945760
  • RosenowFSchade-BrittingerCBurchardiNThe LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy – an open-label, prospective, randomised controlled multicenter studyJ Neurol Neurosurg Psychiatry201283111093109822595362
  • BorggraefeIBonfertMBastTLevetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD Study)Eur J Paediatr Neurol201317550751423642492
  • UCB Pharma SAOpen-label, randomized, active-controlled study of LEV used as monotherapy in patients with partial-onset seizures Available from: https://ClinicalTrials.gov/show/NCT01954121Accessed July 18, 2017
  • TrinkaEMarsonAGvan PaesschenWKOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsyJ Neurol Neurosurg Psychiatry201384101138114722933814
  • University of RochesterA safety and feasibility study of enteral LVT vs. standard of care for seizure control in pediatric CM (LVT2) Available from: https://ClinicalTrials.gov/show/NCT01982812Accessed July 18, 2017
  • RossettiAOJeckelmannSNovyJRothPWellerMStuppRLevetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A Phase II randomized studyNeuro Oncol201416458458824311644
  • ZaccaraGAlmasMPitmanVKnappLPosnerHEfficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trialEpilepsia20145571048105724902473
  • InoueYYagiKIkedaAEfficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizuresPsychiatry Clin Neurosci2015691064064825854635
  • JungDEYuRYoonJRNeuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsyNeurology201584232312231925948717
  • SureshSHChakrabortyAVirupakshaiahAKumarNEfficacy and safety of levetiracetam and carbamazepine as monotherapy in partial seizuresEpilepsy Res Treat20152015416
  • WerhahnKJTrinkaEDobesbergerJA randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsyEpilepsia201556345045925684224
  • HakamiTO’BrienTJPettySJMonotherapy with levetiracetam versus older AEDs: a randomized comparative trial of effects on bone healthCalcif Tissue Int201698655656526842957
  • KimJHLeeSKLoeschCComparison of levetiracetam and oxcarbazepine monotherapy among Korean patients with newly diagnosed focal epilepsy: a long-term, randomized, open-label trialEpilepsia2017584e70e7428395124
  • TackeMGerstlLHeinenFEffect of anticonvulsive treatment on neuropsychological performance in children with BECTSEur J Paediatr Neurol201620687487927553576
  • SiniscalchiAScaglioneFSanzaroEEffects of phenobarbital and levetiracetam on PR and QTc intervals in patients with post-stroke seizureClin Drug Investig20143412879886
  • BootsmaHPRickerLDiepmanLLong-term effects of levetiracetam and topiramate in clinical practice: a head-to-head comparisonSeizure2008171192617618131
  • AndersohnFSchadeRWillichSNGarbeEUse of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behaviorNeurology201075433534020660863
  • ArifHBuchsbaumRPierroJComparative effectiveness of 10 antiepileptic drugs in older adults with epilepsyArch Neurol201067440841520385905
  • MerrellRTAndersonSKMeyerFBLachanceDHSeizures in patients with glioma treated with phenytoin and levetiracetamJ Neurosurg201011361176118120560728
  • RauchenzaunerMBitscheGSvalheimSEffects of levetiracetam and valproic acid monotherapy on sex-steroid hormones in prepubertal children – results from a pilot studyEpilepsy Res2010882–326426820015617
  • VeibyGDaltveitAKEngelsenBAGilhusNEFetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancyJ Neurol2014261357958824449062
  • XiaoFAnDDengHChenSRenJZhouDEvaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS)Seizure201423975676124998415
  • JavedACohenBDetynieckiKRates and predictors of patient-reported cognitive side effects of antiepileptic drugs: an extended follow-upSeizure201529344026076842
  • TinchonAOberndorferSMarosiCHaematological toxicity of valproic acid compared to levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort studyJ Neurol2015262117918625359262
  • TomsonTBattinoDBonizzoniEAntiepileptic drugs and intrauterine death: a prospective observational study from EURAPNeurology201585758058826187231
  • BektaşGTekinUÖzkanMUThe influence of levetiracetam on psychosocial and behavioral functioning in children: a case–control and follow-up studyEpilepsy Behav201772394228575765
  • ChenBChoiHHirschLJPsychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsyEpilepsy Behav201776243128931473
  • EgunsolaOChoonaraISammonsHMWhitehouseWPSafety of antiepileptic drugs in children and young people: a prospective cohort studySeizure201856202529427834
  • FreyNBodmerMBircherAThe risk of Stevens–Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugsEpilepsia201758122178218529027197
  • LeeTWarrickBJSarangarmPLevetiracetam in toxic seizuresClin Toxicol (Phila)201856317518128753046
  • MaschioMZarablaAMaialettiAQuality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: a prospective explorative study with a historical control groupEpilepsy Behav201773838928623754
  • ShihFYChuangYCChuangMJEffects of antiepileptic drugs on thyroid hormone function in epilepsy patientsSeizure20174871028364656
  • StephenLJWishartABrodieMJPsychiatric side effects and anti-epileptic drugs: observations from prospective auditsEpilepsy Behav201771Pt A737828551500
  • NewsomeSDXueLYJenningsTCastanedaGYLevetiracetam-induced diffuse interstitial lung diseaseJ Child Neurol200722562863017690072
  • GalleraniMMariEBoariBCarlettiRMarraACavalloMPancytopenia associated with levetiracetam treatmentClin Drug Investig20092911747751
  • HacquardMRichardSLacourJCLecompteTVespignaniHLevetiracetam-induced platelet dysfunctionEpilepsy Res2009861949619447009
  • HurwitzKAIngulliEGKrousHFLevetiracetam induced interstitial nephritis and renal failurePediatr Neurol2009411575819520278
  • Peer MohamedBMohamedBPPrabhakarPThrombocytopenia as an adverse effect of levetiracetam therapy in a childNeuropediatrics200940524324420221962
  • TamarelleCPanditFMazaratiARiquetAValléeLAuvinSLevetiracetam-induced depression in a 5-year-old child with partial epilepsySeizure200918323523618848469
  • vande GriendJPLinneburSABainbridgeJLProbable levetiracetam-associated depression in the elderly: two case reportsAm J Geriatr Pharmacother20097528128419948304
  • BroliMProviniFNaldiIUnexpected gamma glutamyltransferase rise increase during levetiracetam monotherapyEpileptic Disord2010121818220159672
  • CaraballoRHCersósimoRde Los SantosCLevetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsiesEpileptic Disord201012214615020483715
  • OghlakianRNockCKoubeissiMA case of levetiracetam-induced thrombocytopeniaEpileptic Disord201012433533721078583
  • SahayaKGoyalMKSarwalASinghNNLevetiracetam-induced thrombocytopenia among inpatients: a retrospective studyEpilepsia201051122492249521204814
  • BachmannTBertheussenKHSvalheimSHaematological side effects of antiepileptic drug treatment in patients with epilepsyActa Neurol Scand Suppl20111911912327
  • GivonLPorterSPadmanabhanBGorenJCohenPALevetiracetam, seizures, and suicidalityHarv Rev Psychiatry2011191475521250896
  • AlkhotaniAMclachlanRSLevetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigineSeizure201221540740822524985
  • BabtainFALevetiracetam may worsen myoclonus in patients with juvenile myoclonic epilepsy: case reportsClin Neuropharmacol201235420120222805231
  • Bishop-FreemanSCKornegayNCWineckerREPostmortem levetiracetam (Keppra®) data from North CarolinaJ Anal Toxicol201236642242822635608
  • CalabròRSItalianoDMilitiDBramantiPLevetiracetam-associated loss of libido and anhedoniaEpilepsy Behav201224228328422560189
  • CamachoAEspínJCNuñezNSimónRLevetiracetam-induced reversible autistic regressionPediatr Neurol2012471656722704022
  • ChauKYongJIsmailKGriffithNLiuMMakrisALevetiracetam-induced severe acute granulomatous interstitial nephritisClin Kidney J20125323423626069773
  • Gómez-ZorrillaSFerrazAVPedrósCLemusMPeñaCLevetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndromeAnn Pharmacother2012467–8e2022764327
  • XiongNHouLLuNMohamedAAWangTHuangYProbable levetiracetam-related serum alkaline phosphatase elevationBMC Neurol2012129722994584
  • ZouLPDingCHSongZJLiXFStevens–Johnson syndrome induced by levetiracetamSeizure2012211082382523036769
  • HommetCBeaufilsERoubeauVEncephalopathy induced by levetiracetam in an elderly womanAging Clin Exp Res201325111111323740641
  • KaradagASBilgiliSGCalkaOOnderSKosemMBurakgazi-DalkilicEA case of levetiracetam induced bullous pemphigoidCutan Ocul Toxicol201332217617823030621
  • KaufmanKRBisenVZimmermanATobiaAManiRWongSApparent dose-dependent levetiracetam-induced de novo major depression with suicidal behaviorEpilepsy Behav Case Rep2013111011225667841
  • MetinSZOzmenMOzkaraCOzmenEHypersexuality in a patient with epilepsy during treatment of levetiracetamSeizure201322215115223200413
  • SethiNKSethiPKTorgovnickJArsuraECukierwarFAsymptomatic elevation of liver enzymes due to levetiracetam: a case reportDrug Metabol Drug Interact201328212312423420283
  • AkiyamaHHagaYSasakiNYanagisawaTHasegawaYA case of rhabdomyolysis in which levetiracetam was suspected as the causeEpilepsy Behav Case Rep2014215215525667895
  • AksoyDCevikBKurtSPekdasESolmazVHypokalemia and hypomagnesaemia related to levetiracetam useJ Clin Neurosci201421111989199024906211
  • AzarNJAunePAcute pancreatitis and elevated liver transaminases after rapid titration of oral levetiracetamJ Clin Neurosci20142161053105424291473
  • BuiMBasletGWeisholtzDMcelrathTLevetiracetam-induced psychosis in a pregnant woman with prior substance abuseHarv Rev Psychiatry201422319320024802726
  • HwangESSiemianowskiLASenSPatelRLevetiracetam: an unusual cause of deliriumAm J Ther2014216e225e22823782757
  • IsaacsonJEChoeDJDohertyMJCreatine phosphokinase elevation exacerbated by levetiracetam therapyEpilepsy Behav Case Rep2014218919125667904
  • KokluEArigulogluEAKokluSLevetiracetam-induced anaphylaxis in a neonatePediatr Neurol201450219219424262344
  • KumarNSwaroopHSChakrabortyAChandranSLevetiracetam induced acute reversible psychosis in a patient with uncontrolled seizuresIndian J Pharmacol201446556056125298593
  • ParkEMHolmesJAReeder-HayesKEAcute mania associated with levetiracetam treatmentPsychosomatics20145519810023932538
  • SpenglerDCMontourisGDHohlerADLevetiracetam as a possible contributor to acute kidney injuryClin Ther201436813031306
  • ZakiSAGuptaSLevetiracetam-induced acute psychosis in a childIndian J Pharmacol201446334134224987186
  • ZouXHongZZhouDHair loss with levetiracetam in five patients with epilepsySeizure201423215816024315496
  • ArıHKahramanFAcabanMBThe first case of levetiracetam-induced and tolvaptan-resistant hyponatremiaTurk Kardiyol Dern Ars201543328428725906002
  • EleniKDress syndrome induced by levetiracetamJ Eur Acad Dermatol Venereol201529237737824397826
  • FlanneryAHWilleyMDThompson BastinMLBuchKPBensadounESEosinophilia and fever with levetiracetam: a case reportPharmacotherapy2015358e131e13526235978
  • FujikawaMKishimotoYKakisakaYObsessive–compulsive behavior induced by levetiracetamJ Child Neurol201530794294425008911
  • GenclerOSGenclerBAltunelCTArslanNLevetiracetam induced psoriasiform drug eruption: a rare case reportSaudi Pharm J201523672072226702269
  • KawakamiYOkazakiTTakaseMFujinoOItohYA girl with idiopathic epilepsy showing forced normalization after levetiracetam administrationJ Nippon Med Sch201582525025326568392
  • MakkeYHmaimessGNasreddineWFawazABeydounAParadoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsyBMC Pediatr201515625884503
  • MolokwuOAEzeala-AdikaibeBAOnwuekweIOLevetiracetam-induced rage and suicidality: two case reports and review of literatureEpilepsy Behav Case Rep20154798126543810
  • PeyrlAWeichertNKühlJSEbellWHernáiz DrieverPLevetiracetam as a possible cause of secondary graft failure after allogenic hematopoietic stem cell transplantationEur J Paediatr Neurol2015191757725468262
  • Taberner BonastreMTPeralta MuñozSBozaFMGumàIPadróJNeutropenia secondary to exposure to levetiracetamTumori20151015145146
  • BayramAKCanpolatMÇınarSLDrug reaction with eosinophilia and systemic symptoms syndrome induced by levetiracetam in a pediatric patientJ Emerg Med2016502e61e6626597350
  • DarWRSofiNLatiefMDarIAKasanaBALevetiracetam induced drug reaction with eosinophilia and systemic symptom syndromeIndian J Dermatol2016612235
  • García CarreteroRRomero BrugeraMOlid-VelillaMSalamanca-RamirezIPancytopenia associated with levetiracetam in an epileptic womanBMJ Case Rep20162016bcr2016217407
  • JonesRTEvansWMersfelderTLKavanaughKRare red rashes: a case report of levetiracetam-induced cutaneous reaction and review of the literatureAm J Ther2016233e944e94625259954
  • JuJZouLPShiXYHuLYPangLYLevetiracetam: probably associated diurnal frequent urinationAm J Ther2016232e624e62726938751
  • TuratiMGlardYAfonsoDGriffetJBigoniMOsteochondral alteration in a child treated with levetiracetam: a rare case of juvenile osteochondritis dissecans of the talar headJ Pediatr Orthop B201726218919227341121
  • KubotaKYamamotoTKawamotoMLevetiracetam-induced rhabdomyolysis: a case report and literature reviewNeurol Asia201722275278
  • OzdemirHSumerSKarabagliHB cell aplasia and hypogammaglobulinemia associated with levetiracetamAnn Saudi Med2018381545548
  • SereflicanBKarapinarTDuzcuSETurkogluŞADisseminated eruptive granuloma annulare induced by levetiracetamCutan Ocul Toxicol201736330030128095713
  • BeghiEAtzeniLGarattiniLEconomic analysis of newer antiepileptic drugsCNS Drugs2008221086187518788837
  • SuhGHLeeSKEconomic evaluation of add-on levetiracetam for the treatment of refractory partial epilepsy in KoreaPsychiatry Investig200963185193
  • TomsonTBattinoDBonizzoniEComparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registryLancet Neurol201817653053829680205
  • KimJKondratyevAGaleKAntiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapyJ Pharmacol Exp Ther2007323116517317636003
  • CumboELigoriLDLevetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer’s diseaseEpilepsy Behav201017446146620188634
  • ChanRWeiCYChenYTBenetLZUse of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to help predict the occurrence of idiosyncratic cutaneous adverse drug reactions associated with antiepileptic drug usageAAPS J201618375776626951484
  • FongJKChanELLeungHAn update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong KongHong Kong Med J2017231748828184017
  • WijnenBFMvan MastrigtGEversSA systematic review of economic evaluations of treatments for patients with epilepsyEpilepsia201758570672628098939
  • KazerooniRBounthavongMCost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injuryClinicoecon Outcomes Res20102152321935311
  • LyttleMDGambleCMessahelSEmergency treatment with levetiracetam or phenytoin in status epilepticus in children – the EcLiPSE study: study protocol for a randomised controlled trialTrials201718128328629473
  • BährOHermissonMRonaSIntravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trialActa Neurochir (Wien)2012154222923521909835
  • KellinghausCStögbauerFTreatment of status epilepticus in a large community hospitalEpilepsy Behav201223323524022341964